Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Alderson

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Vaccine|April 17, 2016
Status of research and development of pediatric vaccines for Streptococcus pneumoniaeMark R Alderson
The New England Journal of Medicine|August 17, 2023
Meningococcal Vaccine in Mali and Gambia. ReplyEd Clarke, Mark R Alderson, Milagritos D Tapia
Journal of Endotoxin Research|October 25, 2006
TLR4 agonists as immunomodulatory agentsMark R Alderson, Patrick McGowan, Jory R Baldridge, et al.
Expert Review of Vaccines|March 3, 2012
Issues and challenges in the development of pneumococcal protein vaccinesAmy Sarah Ginsburg, Moon H Nahm, Farukh M Khambaty, et al.
Human Vaccines & Immunotherapeutics|February 24, 2021
Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (<i>PNEUMOSIL®</i>)Mark R Alderson, Vistasp Sethna, Lauren C Newhouse, et al.
Infection and Immunity|November 24, 2004
Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infectionAna Gervassi, Mark R Alderson, Robert Suchland, et al.
Microorganisms|April 30, 2021
Vaccines to Prevent Meningitis: Historical Perspectives and Future DirectionsMark R Alderson, Jo Anne Welsch, Katie Regan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Functional characterization of class Ia- and non-class Ia-restricted Chlamydia-reactive CD8+ T cell responses in humansAna L Gervassi, Peter Probst, Walter E Stamm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatisAna L Gervassi, Kenneth H Grabstein, Peter Probst, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2003
Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cellsDeborah A Lewinsohn, Amy S Heinzel, James M Gardner, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Vaccine|April 17, 2016
Status of research and development of pediatric vaccines for Streptococcus pneumoniaeMark R Alderson
The New England Journal of Medicine|August 17, 2023
Meningococcal Vaccine in Mali and Gambia. ReplyEd Clarke, Mark R Alderson, Milagritos D Tapia
Journal of Endotoxin Research|October 25, 2006
TLR4 agonists as immunomodulatory agentsMark R Alderson, Patrick McGowan, Jory R Baldridge, et al.
Expert Review of Vaccines|March 3, 2012
Issues and challenges in the development of pneumococcal protein vaccinesAmy Sarah Ginsburg, Moon H Nahm, Farukh M Khambaty, et al.
Human Vaccines & Immunotherapeutics|February 24, 2021
Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (<i>PNEUMOSIL®</i>)Mark R Alderson, Vistasp Sethna, Lauren C Newhouse, et al.
Infection and Immunity|November 24, 2004
Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infectionAna Gervassi, Mark R Alderson, Robert Suchland, et al.
Microorganisms|April 30, 2021
Vaccines to Prevent Meningitis: Historical Perspectives and Future DirectionsMark R Alderson, Jo Anne Welsch, Katie Regan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Functional characterization of class Ia- and non-class Ia-restricted Chlamydia-reactive CD8+ T cell responses in humansAna L Gervassi, Peter Probst, Walter E Stamm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Human CD8+ T cells recognize the 60-kDa cysteine-rich outer membrane protein from Chlamydia trachomatisAna L Gervassi, Kenneth H Grabstein, Peter Probst, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2003
Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cellsDeborah A Lewinsohn, Amy S Heinzel, James M Gardner, et al.
Pageof 4